IP Verse

Aptalis Pharma patent opposition analysis

Get complete Patent Opposition Report for Aptalis Pharma

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest patents of Aptalis Pharma opposed by its competitors

Explore Aptalis Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent Number	Grant Date	Title	Total Oppositions
EP3024479	Feb 8, 2023	High Potency Pancreatin Pharmaceutical Compositions	1
EP3003360	Oct 7, 2020	High Potency Pancreatin Pharmaceutical Compositions	1
EP2646003	Jun 3, 2020	Rapidly Dispersing Granules, Orally Disintegrating Tablets And Methods	1
EP2477645	Aug 15, 2018	Pancreatic Enzyme Compositions And Methods For Treating Pancreatitis And Pancreatic Insufficiency	2
EP2482822	Aug 1, 2018	Orally Administered Corticosteroid Compositions	1
EP2818160	Nov 8, 2017	Enteric Coated, Low-Strength Pancrelipase Formulations	1

Top competitors of Aptalis Pharma

MATHYS & SQUIRE

DR FALK PHARMA

CAMULON